Lyophilisate For The Preparation Of A Solution Of A Radiopharmaceutical Drug By The Method Of Labeling With A Solution Of Sodium Pertechnetate (Na99mtc04) For Intravenous Administration. One Vial Contains: Tin Dichloride 0.05 Mg, Copper Tetramibe Tetrafluoroborate 0.80 Mg, L-Cysteine Hydrochloride Monohydrate 1.2 Mg, Mannitol - 10.0 Mg, Sodium Dihydrocitrate 11.0 Mg. Active Substance: Copper Tetramibe Tetrafluoroborate Packaging: In Vials For Medicinal Products With A Capacity Of 10 Ml. Vials Are Hermetically Sealed With Rubber Stoppers And Crimped With Aluminum Or Aluchine-Plastic Caps. 5 Vials With Lyophilisate Are Placed In A Contour Cell Packaging Made Of Polyvinyl Chloride Film, Together With A Passport And Instructions For The Preparation And Use Of The Drug In A Cardboard Box. Sterile. The Drug Is Used To Identify Foci Of Pathological Resorption And Areas Of Increased Metabolism In The Tissue Of The Parathyroid Gland. To Assess The Perfusion Of The Myocardium In Various Pathological Processes Leading To A Violation Of Its Blood Supply (Coronary Atherosclerosis, Acute Myocardial Infarction, Postinfarction And Postmyocardial Cardiosclerosis, Ischemic Heart Disease). Deviation From The Temperature Regime (18-25Oc) During Transportation Within 1 Month Is Allowed. The Shelf Life Is Not Less Than 8 Months. One Package Contains 5 Bottles, Lyophilisate For The Preparation Of A Solution Of A Radiopharmaceutical Drug By The Method Of Labeling With A Solution Of Sodium Pertechnetate (Na99mtc04) For Intravenous Administration. One Bottle Contains: Divalent Tin In The Form Of The Interaction Products Of Anhydrous Tin Difluoride, Oxabifor Acid And Oxabifor Sodium 0.10 Mg, Phosphorus In The Form Of Oxabifor Acid, Sodium Oxabifor And The Products Of Their Interaction With Tin Difluoride 1.25 Mg. Active Substance: Oxabifor Acid And Sodium Oxabifor. Packaging In A Cardboard Box: In Bottles Of 5 Bottles Of 10 Ml Each With A Passport And Instructions For Preparation And Use Of The Drug. Sterile. The Drug Is Used To Identify Foci Of Pathological Resorption And Areas Of Increased Metabolism In Bone Tissue With Various Pathological Processes In The Skeleton By The Method Of Single-Photon Emission Computer Tomography. Deviation From The Temperature Regime (18-25Oc) Is Allowed During Transportation For 1 Month. The Shelf Life Is Not Less Than 8 Months. One Package Contains 5 Bottles, Radiopharmaceutical Diagnostic Tool 99M Tc. Contains 4.8 Mg Of Calcium Trisodium Pentetate, Packaged In 5 Ml Vials. Sterile. Lyophilisate For Preparation Of Solution For Intravenous Injections, Based On Isotope 99Mts (Technetium) With A Half-Life Of 6.04 H. When Decaying, 99Mts Emits Gamma Rays With An Energy Of 140 Kev And A Yield Of 90%. Pentatech, 99Mts After Intravenous Administration Is Removed From The Blood Due To Glomerular Filtration And Exit To The Extracellular Space. Secretion And Reabsorption Of The Drug In The Tubules Of The Nephron Does Not Occur. The Above-Mentioned Mechanism Of Excretion Of The Drug 99Mts By The Kidneys Provides The Opportunity To Use It For Kidney Research. There Are 5 Bottles In The Package. The Shelf Life Is Not Less Than 8 Months From The Date Of Delivery To The Customer.
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
